Orexo announces new Executive Management Team
Following the completion of the Biolipox acquisition, Orexo has appointed a new Executive Management Team. The new Executive Management Team consists of Torbjörn Bjerke (President & CEO), Claes Wenthzel (Executive Vice President & CFO), Thomas Lundqvist (Executive Vice President och Executive Advisor), Göran Smedegård (Vice President Business Development & Commercial Development) and Göran Tornling (Executive Vice President R&D).”Orexo has a clear objective – to commercialize the product portfolio through partnerships and licensing agreements with other pharmaceutical companies. The main